Henry Schein, Inc. logo

Henry Schein, Inc. (HS2)

Market Open
13 Feb, 12:44
XFRA XFRA
74. 06
+0.08
+0.11%
- Market Cap
21.94 P/E Ratio
0% Div Yield
0 Volume
4.54 Eps
73.98
Previous Close
Day Range
74.04 74.06
Year Range
58.62 78.96
Want to track HS2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 61 days

Summary

HS2 trading today higher at €74.06, an increase of 0.11% from yesterday's close, completing a monthly increase of 0% or €74.06. Over the past 12 months, HS2 stock gained 10.87%.
HS2 is not paying dividends to its shareholders.
The last earnings report, released on Aug 05, 2025, missed the consensus estimates by -1.19%. On average, the company has fell short of earnings expectations by -0.4%, based on the last three reports. The next scheduled earnings report is due on Nov 03, 2025.
Henry Schein, Inc. has completed 1 stock splits, with the recent split occurring on Sep 15, 2017.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

HS2 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Henry Schein: The Case For An Upgrade From Hold To Buy

Henry Schein: The Case For An Upgrade From Hold To Buy

Henry Schein is transitioning to higher-margin businesses, with strong tailwinds in dental and medical markets, and is now fairly valued after previous overvaluation. KKR's strategic investment and restructuring support, plus resolution of past issues like the cyber incident, position HSIC for margin improvement and renewed growth. Despite recent stagnation, margin compression, and tariff headwinds, management is actively addressing challenges through efficiency initiatives and product mix shifts.

Seekingalpha | 2 weeks ago
Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript

Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript

Henry Schein, Inc. (NASDAQ:HSIC ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Graham Stanley - VP of Investor Relations & Strategic Finance Project Officer Ronald N. South - Senior VP & CFO Stanley M.

Seekingalpha | 4 weeks ago
Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say

Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 4 weeks ago

Henry Schein, Inc. Dividends

HS2 is not paying dividends to its shareholders.

Henry Schein, Inc. Earnings

4 Nov 2025 (In 2 months) Date
1.28
Cons. EPS
-
EPS
3 Nov 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
5 Aug 2025 Date
1.19
Cons. EPS
-
EPS
4 Aug 2025 Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS
HS2 is not paying dividends to its shareholders.
4 Nov 2025 (In 2 months) Date
1.28
Cons. EPS
-
EPS
3 Nov 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
5 Aug 2025 Date
1.19
Cons. EPS
-
EPS
4 Aug 2025 Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS

Henry Schein, Inc. (HS2) FAQ

What is the stock price today?

The current price is €74.06.

On which exchange is it traded?

Henry Schein, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is HS2.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Nov 03, 2025.

Has Henry Schein, Inc. ever had a stock split?

Henry Schein, Inc. had 1 splits and the recent split was on Sep 15, 2017.

Henry Schein, Inc. Profile

Medical - Distribution Industry
Healthcare Sector
Stanley M. Bergman CPA CEO
XFRA Exchange
US8064071025 ISIN
US Country
25,000 Employees
- Last Dividend
8 Feb 2019 Last Split
3 Nov 1995 IPO Date

Overview

Henry Schein, Inc. stands as a pivotal provider of healthcare products and services tailored for dental practitioners, laboratories, physician practices, and ambulatory surgery centers. It also extends its offerings to government and institutional health care clinics, and various alternate care clinics globally. Founded in 1932, with its headquarters nestled in Melville, New York, Henry Schein operates through two principal segments: Health Care Distribution, and Technology and Value-Added Services. The company's vast reach and diverse portfolio allow it to be an influential player in promoting wellness and efficiency across the healthcare landscape.

Products and Services

  • Health Care Distribution

    This segment delivers an extensive range of dental products including essential infection-control products, handpieces, preventatives, and materials for impressions and restorations. It encompasses everything from anesthetics, teeth, and implants, to advanced dental equipment such as chairs, delivery units, lights, and X-ray supplies. Moreover, the division offers pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins, catering not just to dental, but also medical needs. Noteworthy is its inclusion of personal protective equipment and services for equipment repair, highlighting its commitment to safety and reliability in healthcare supplies.

  • Technology and Value-Added Services

    This segment is dedicated to enhancing healthcare practices through innovative software, technology solutions, and supplementary services. It features practice management software systems designed for dental and medical practitioners, aiming to streamline workflows and improve operational efficiency. Further amplifying its value proposition, Henry Schein provides a suite of value-added practice solutions. These encompass consultancy services, education, revenue cycle management, financial services, e-services, and support for practice technology. Also available are network and hardware services, consulting, and continuing education services. This multifaceted approach helps practitioners focus on patient care while optimizing their practice's performance and profitability.

Contact Information

Address: 135 Duryea Road
Phone: 631 843 5500